IP Library Granted Patent US 6,855,489
Granted Patent B1
US 6,855,489 · App. 09/688,079 · Granted Feb 15, 2005

Systems and methods for removing viral agents from blood

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,855,489
App. No.
09/688,079
Granted
Feb 15, 2005
Kind
B1
Abstract

Systems and methods treat plasma carrying contaminants and cellular matter that are capable of entraining contaminants. The systems and methods separate cellular matter from the plasma by filtration, thereby removing contaminants entrained within the cellular matter. The system and methods add to the plasma a photoactive material. The systems and methods emit radiation at a selected wavelength into the plasma to activate the photoactive material and thereby eradicate the contaminant that is free of entrainment by cellular matter.

Claims (20)

1. A kit comprising

tubing adapted to be coupled to a blood constituent source to convey blood constituent,

a source of photoactive material to be mixed with the blood constituent,

a transfer container coupled to the tubing, the transfer container including a wall made of a material that is transparent to light that activates the photoactive material, and

a removable overwrap separate from the wall of the container, the overwrap enveloping the source of photoactive material within the kit said overwrap including a light filtering material that is not transparent to light in the activating spectrum for said photoactive material thereby preventing degradation of the photoactive material prior to removal of the overwrap.

2. A kit according to claim 1

wherein the photoactive material includes methylene blue.

3. A kit according to claim 2

wherein the light filtering material includes a blue material.

4. A kit according to claim 3

wherein the blue material includes phtalocyanine pigments.

5. A kit according to claim 1

wherein the photoactive material includes psoralen.

6. A kit according to claim 5

wherein the light filtering material includes a red material.

7. A kit according to claim 1

wherein the overwrap envelops the entire kit.

8. A kit according to claim 1 further including

wherein the tubing includes a first filtration media to separate a first cellular blood species from the blood constituent conveyed from the blood constituent source, and

wherein the tubing also includes a second filtration media in series with the first filtration media to second cellular blood species from the blood constituent conveyed from the blood constituent source, to thereby produce a filtered blood constituent that is essentially free of the first and second cellular blood species.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0549 →
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2012
From: MORGAN STANLEY & CO. LLC
To: FENWAL, INC.; FENWAL HOLDINGS, INC.
Reel/Frame 029480/0597 →
SECOND-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 15, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019297/0168 →
FIRST-LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2007
From: FENWAL, INC.; FENWAL HOLDINGS, INC.
To: MORGAN STANLEY & CO. INCORPORATED
Reel/Frame 019280/0211 →
PATENT ASSIGNMENT Recorded Apr 6, 2007
From: BAXTER INTERNATIONAL INC.
To: FENWAL, INC.
Reel/Frame 019129/0001 →